0001628280-24-012780.txt : 20240322 0001628280-24-012780.hdr.sgml : 20240322 20240322192218 ACCESSION NUMBER: 0001628280-24-012780 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240321 FILED AS OF DATE: 20240322 DATE AS OF CHANGE: 20240322 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: HIBBS KATHY L CENTRAL INDEX KEY: 0001267487 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39587 FILM NUMBER: 24776623 MAIL ADDRESS: STREET 1: C/O VIROLOGIC STREET 2: 345 OYSTER POINT BLVD CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: 23andMe Holding Co. CENTRAL INDEX KEY: 0001804591 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 871240344 FISCAL YEAR END: 0331 BUSINESS ADDRESS: STREET 1: 349 OYSTER POINT BOULEVARD CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: (650) 938-6300 MAIL ADDRESS: STREET 1: 349 OYSTER POINT BOULEVARD CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 FORMER COMPANY: FORMER CONFORMED NAME: VG Acquisition Corp. DATE OF NAME CHANGE: 20200915 FORMER COMPANY: FORMER CONFORMED NAME: Virgin Group Acquisition Corp. DATE OF NAME CHANGE: 20200909 FORMER COMPANY: FORMER CONFORMED NAME: Bleecker Street Acquisition Corp. DATE OF NAME CHANGE: 20200225 4 1 wk-form4_1711149730.xml FORM 4 X0508 4 2024-03-21 0 0001804591 23andMe Holding Co. ME 0001267487 HIBBS KATHY L C/O 23ANDME HOLDING CO. 349 OYSTER POINT BLVD SOUTH SAN FRANCISCO CA 94080 0 1 0 0 Chief Administrative Officer 1 Class A Common Stock 2024-03-21 4 M 0 38548 0.42 A 1290863 D Class A Common Stock 2024-03-21 4 S 0 38548 0.4642 D 1252315 D Stock Option (Right to Buy) 0.42 2024-03-21 4 M 0 38548 0 D 2024-05-04 Class A Common Stock 38548 115647 D The sale reported on this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 9, 2023. The sale price reported in Column 4 of Table 1 represents the weighted average sale price of the shares sold ranging from $0.4600 to $0.4748. Upon request by the staff of the Securities and Exchange commission, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price. The stock options vested 25% after 12 months of service and on a pro rata basis (in remaining 1/48 installments) over the following 36 months of service beginning on April 1, 2014. /s/ Kathy Hibbs 2024-03-22